4.3 Article

Effect of mild hyperglycemia on autonomic function in obstructive sleep apnea

Journal

CLINICAL AUTONOMIC RESEARCH
Volume 22, Issue 1, Pages 1-8

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s10286-011-0131-9

Keywords

Sleep apnea obstructive; Hyperglycemia; Autonomic nervous system

Funding

  1. NIH [1K23 NS056009-01A1, 1PO1 HL56693]
  2. Vanderbilt CTSA [1 UL1 RR024975]

Ask authors/readers for more resources

Introduction Obstructive sleep apnea (OSA) has been hypothesized to cause a hypersympathetic state, which may be the mechanism for the increased incidence of cardiovascular disease in OSA. However, there is a high prevalence of hyperglycemia in OSA patients, which may also contribute to autonomic dysfunction. Methods Thirty-five patients with OSA and 11 controls with average body mass index (BMI) of 32.0 +/- 4.6 underwent polysomnography, glucose tolerance testing, autonomic function tests, lying and standing catecholamines, overnight urine collection, and baseline ECG and continuous blood pressure measurements for spectral analysis. A linear regression model adjusting for age and BMI was used to analyze spectral data, other outcome measures were analyzed with Kruskal-Wallis test. Results Twenty-three OSA patients and two control patients had hyperglycemia (based on 2001 American Diabetes Association criteria). Apnea-hypopnea index (AHI) correlated with total power and low frequency (LF) power (r = 0.138, 0.177, p = 0.031; and r = 0.013) but not with the LF/high frequency (HF) ratio (p = 0.589). Glucose negatively correlated with LF systolic power (r = -0.171, p = 0.038) but not AHI (p = 0.586) and was marginally associated with pnn50, total power, LF, and HF power (p ranged from 0.07 to 0.08). Conclusion These data suggest that patients with OSA and mild hyperglycemia have a trend towards lower heart rate variability and sympathetic tone. Hyperglycemia is an important confounder and should be evaluated in studies of OSA and autonomic function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts

Stephen A. Goutman, Kai Guo, Masha G. Savelieff, Adam Patterson, Stacey A. Sakowski, Hani Habra, Alla Karnovsky, Junguk Hur, Eva L. Feldman

Summary: By performing untargeted metabolomics in two independent ALS cohorts, this study identifies recurring pathways that are altered in both cohorts. Many of the pathways are involved in lipid metabolism, including beta-oxidation intermediates and complex and signalling lipids, such as sphingolipids and diacylglycerols.

BRAIN (2022)

Article Endocrinology & Metabolism

Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status

Kai Guo, Masha G. Savelieff, Amy E. Rumora, Fadhl M. Alakwaa, Brian C. Callaghan, Junguk Hur, Eva L. Feldman

Summary: This study aimed to identify the plasma metabolomics and lipidomics signature that underlies PN in individuals with average class 3 obesity. The analysis showed significant differences in metabolites and lipids between lean and obese individuals, regardless of PN status. Stratification by PN status within obese individuals revealed differences in specific metabolic and lipid pathways.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Public, Environmental & Occupational Health

Associations of self-reported occupational exposures and settings to ALS: a case-control study

Stephen A. Goutman, Jonathan Boss, Christopher Godwin, Bhramar Mukherjee, Eva L. Feldman, Stuart A. Batterman

Summary: Occupational exposure to particulate matter, volatile organic compounds, metals, pesticides, and combustion and diesel exhaust, as well as employment in production occupations, are associated with an increased risk of ALS.

INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2022)

Article Biochemistry & Molecular Biology

miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis

Junguk Hur, Ximena Paez-Colasante, Claudia Figueroa-Romero, Ting-wen Lo, Sami J. Barmada, Michelle T. Paulsen, Mats Ljungman, Fadhl M. Alakwaa, Masha G. Savelieff, Stephen A. Goutman, Eva L. Feldman

Summary: This study analyzes the miRNA profiles in patients with amyotrophic lateral sclerosis (ALS) and identifies different miRNA levels in different ALS mutation types. The study also reveals pathways related to ALS and suggests potential targets for future research. These findings contribute to the early diagnosis of ALS.

HUMAN MOLECULAR GENETICS (2022)

Article Clinical Neurology

Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles

Stephen A. Goutman, Jonathan Boss, Gayatri Iyer, Hani Habra, Masha G. Savelieff, Alla Karnovsky, Bhramar Mukherjee, Eva L. Feldman

Summary: This study found that ALS participants experienced weight loss in the 5 years before enrollment, and long-term decrease in BMI was associated with lower survival rates. Metabolomic profiles were also found to be associated with BMI trajectories. Replicating these findings in other cohorts is necessary.

MUSCLE & NERVE (2023)

Review Endocrinology & Metabolism

Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review

Melissa A. Elafros, Brian C. Callaghan, Lesli E. Skolarus, Loretta Vileikyte, John G. Lawrenson, Eva L. Feldman

Summary: Knowledge about microvascular complications of diabetes varies among patients and healthcare providers, with factors such as education level, disease duration, and socioeconomic status influencing patient knowledge. Misconceptions regarding appropriate screening practices for complications are common among healthcare providers. Further research is needed to identify interventions that can improve knowledge and outcomes for both patients and providers.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2023)

Article Clinical Neurology

Occupational history associates with ALS survival and onset segment

Stephen A. Goutman, Jonathan Boss, Christopher Godwin, Bhramar Mukherjee, Eva L. Feldman, Stuart A. Batterman

Summary: This study aimed to investigate the associations between occupational settings, self-reported occupational exposures, and survival and onset segment of ALS. The findings suggest that work in production occupations, military occupations, and self-reported occupational pesticide exposure are associated with poorer survival. Furthermore, specific occupational settings and exposures are associated with different onset segments of ALS.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2023)

Article Biochemistry & Molecular Biology

Single-cell RNA-seq uncovers novel metabolic functions of Schwann cells beyond myelination

Stephanie A. Eid, Mohamed Noureldein, Bhumsoo Kim, Lucy M. Hinder, Faye E. Mendelson, John M. Hayes, Junguk Hur, Eva L. Feldman

Summary: This study characterized the transcriptional profiles and intercellular communication of Schwann cells (SCs) in a mouse model of prediabetes and neuropathy. The results revealed that SCs can adapt to metabolic stress and inflammation by altering their intercellular communication, which influences the progression of nerve pathophysiology. This study provides important insights into the function and communication mechanisms of SCs in nerve pathology.

JOURNAL OF NEUROCHEMISTRY (2023)

Review Neurosciences

New perspectives in diabetic neuropathy

Stephanie A. Eid, Amy E. Rumora, Bogdan Beirowski, David L. Bennett, Junguk Hur, Masha G. Savelieff, Eva L. Feldman

Summary: The prevalence of diabetes is increasing due to the aging population, with type 2 diabetes being the most common type. Diabetic peripheral neuropathy is a complication that damages peripheral nerves and is influenced by metabolic and bioenergetic dysfunction. Recent evidence suggests that obesity and dyslipidemia also contribute to this condition.

NEURON (2023)

Article Clinical Neurology

Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells

Ayse J. Muniz, Tugba Topal, Michael D. Brooks, Angela Sze, Do Hoon Kim, Jacob Jordahl, Joe Nguyen, Paul H. Krebsbach, Masha G. Savelieff, Eva L. Feldman, Joerg Lahann

Summary: In this study, scientists developed an engineered extracellular matrix (EECM) to provide support and cell-to-matrix interactions for developing brain organoids. Compared to conventional protein matrix, EECMs enhanced neurogenesis, glial maturation, and neuronal diversity. The EECMs also supported long-term culture and produced brain organoids with increased protein diversity.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Multidisciplinary Sciences

Single-cell RNA sequencing identifies hippocampal microglial dysregulation in diet-induced obesity

Rosemary E. Henn, Kai Guo, Sarah E. Elzinga, Mohamed H. Noureldein, Faye E. Mendelson, John M. Hayes, Diana M. Rigan, Masha G. Savelieff, Junguk Hur, Eva L. Feldman

Summary: Obesity is a global concern associated with cognitive impairment. It induces brain inflammation and activates microglia, leading to synaptic spine phagocytosis and cognitive impairment. The mechanisms of microglial activation during obesity are not fully understood.

ISCIENCE (2023)

Article Clinical Neurology

Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort

Stephen A. Goutman, Jonathan Boss, Dae-Gyu Jang, Bhramar Mukherjee, Rudy J. Richardson, Stuart Batterman, Eva L. Feldman

Summary: This study aimed to replicate previous findings regarding the association between persistent organic pollutants (POPs) and amyotrophic lateral sclerosis (ALS) risk and survival. The analysis of samples from 164 ALS patients and 105 control participants showed that several POPs were significantly associated with ALS risk, and the combined mixture of all POPs was associated with ALS survival.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Review Clinical Neurology

The amyotrophic lateral sclerosis exposome: recent advances and future directions

Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, Junguk Hur, Eva L. Feldman

Summary: Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration, with both genetic and environmental factors contributing to the risk and rate of disease progression. Epidemiological studies suggest potential contributions to the ALS exposome from pesticides, occupational exposures, sports and physical activity, metals, air pollution, trauma, electromagnetic fields, the gut microbiome, diet and lifestyle factors. The mechanisms underlying the effects of environmental factors on ALS risk remain incompletely understood but might involve neurotoxicity from specific environmental toxins, microbiome-mediated changes, epigenetic restructuring, systemic and central inflammation, and excitotoxicity. Most studies of the ALS exposome have a retrospective design using questionnaires and are, therefore, prone to recall bias and other limitations. Future studies will require prospective, longitudinal designs that include quantification of exposures in biosamples in addition to questionnaires.

NATURE REVIEWS NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Non-invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1H magnetic resonance spectroscopy

In-Young Choi, Wen-Tung Wang, Bhumsoo Kim, Junguk Hur, David C. Robbins, Dae-Gyu Jang, Masha G. Savelieff, Eva L. Feldman, Phil Lee

Summary: This study characterized the metabolic changes in the brain of patients with T2D using in vivo H-1 magnetic resonance spectroscopy. Elevated levels of several metabolites were observed in both T2D patients and T2D mice, indicating the impact of poorly controlled hyperglycemia on brain metabolism. The study demonstrates the utility of H-1 magnetic resonance spectroscopy in monitoring and understanding the metabolic changes in T2D progression.

JOURNAL OF NEUROCHEMISTRY (2023)

Review Clinical Neurology

Towards prevention of diabetic peripheral neuropathy : clinical presentation, pathogenesis, and new treatments

Melissa A. Elafros, Henning Andersen, David L. Bennett, Masha G. Savelieff, Vijay Viswanathan, Brian C. Callaghan, Eva L. Feldman

Summary: Diabetic peripheral neuropathy is a common complication of diabetes, and early diagnosis and treatment are crucial for improving patients' quality of life. Hyperglycemia and metabolic syndrome are major risk factors for the development of diabetic peripheral neuropathy.

LANCET NEUROLOGY (2022)

No Data Available